Cardiovascular Fixed Dose Combination Pill: A Pharmacodynamic Interaction Study to Evaluate the Effect of a Fixed Dose Combination of Acetylsalicylic Acid, Simvastatin and Ramipril (Cardiovascular Fixed Dose Combination Pill) on Blood Pressure.

Trial Profile

Cardiovascular Fixed Dose Combination Pill: A Pharmacodynamic Interaction Study to Evaluate the Effect of a Fixed Dose Combination of Acetylsalicylic Acid, Simvastatin and Ramipril (Cardiovascular Fixed Dose Combination Pill) on Blood Pressure.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 25 Jun 2015

At a glance

  • Drugs Aspirin/ramipril/simvastatin (Primary) ; Ramipril
  • Indications Embolism and thrombosis; Hypertension
  • Focus Therapeutic Use
  • Sponsors Ferrer
  • Most Recent Events

    • 10 Jul 2011 Planned end date changed from 1 Apr 2011 to 1 Oct 2010 as reported by ClinicalTrials.gov.
    • 10 Mar 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 14 Jun 2010 Planned end date changed from 1 Aug 2010 to 1 Apr 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top